货号:A1365956 同义名: FGI-106 tetrahydrochloride
FGI-106 4HCl是一种广谱抗病毒抑制剂,对多种病毒具有抑制活性,包括 EC50 为 100 nM 的埃博拉病毒、800 nM 的裂谷热病毒、400-900 nM 的登革热病毒,以及 200 nM 的非失血性发热病毒 HCV 和 150 nM 的 HIV-1。
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | FGI-106 tetrahydrochloride acts as a potent, broad-spectrum antiviral, effective against various viruses including Ebola, Rift Valley, and Dengue Fever, with EC50s of 100 nM, 800 nM, and 400-900 nM, respectively. It also targets non-hemorrhagic fever viruses like HCV and HIV-1, with EC50s of 200 nM and 150 nM, respectively[1]. |
体内研究 | FGI-106 treatment (0.1-5 mg/kg; intraperitoneal injection; treatments on days 2 and 5; C57BL/6 or BALB/c mice) reduces mortality caused by Zaire EBOV in a dose-dependent fashion [1]. |
体外研究 | Treatment with 2 μM FGI-106 resulted in a 4-log decrease in infectious viral titers compared to controls, with an EC90 for viral killing inhibition of host cells (Vero E6 cells) estimated at 0.6 μM[1]. In cell-based assays, FGI-106 treatment suppresses viral replication across diverse virus families, encompassing both positive and negative-strand RNA viruses[1]. |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.65mL 0.33mL 0.17mL |
8.27mL 1.65mL 0.83mL |
16.54mL 3.31mL 1.65mL |
CAS号 | 1149348-10-6 |
分子式 | C28H42Cl4N6 |
分子量 | 604.48 |
别名 | FGI-106 tetrahydrochloride |
运输 | 蓝冰 |
存储条件 |
粉末 Keep in dark place,Inert atmosphere,Store in freezer, under -20°C 液体 -20°C:3-6个月-80°C:12个月 |
溶解度 |
DMSO: 5 mg/mL(8.27 mM),配合低频超声,水浴加热至45℃,并调节pH至2,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
动物实验配方 |